SCHEMBL3759336

SCHEMBL3759336

CN1CCN(Cc2cccc(-c3cc(-c4c(N5CCOCC5)sc5c4CC(C)(C)CC5=O)ccn3)c2)CC1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PSMB8 P28062 1/20 0.37
MAPKAPK2 P49137 1/20 0.36
PIK3CD O00329 4/20 0.35
DRD2 P14416 1/20 0.35
DRD4 P21917 1/20 0.35
DRD3 P35462 1/20 0.35
PIK3CB P42338 3/20 0.35
PIK3R1 P27986 2/20 0.35
PIK3CA P42336 4/20 0.34
BUB1 O43683 1/20 0.34
TGFBR1 P36897 2/20 0.34
JAK2 O60674 2/20 0.34
JAK3 P52333 2/20 0.34
PIP5K1C O60331 1/20 0.34
KIT P10721 1/20 0.34
PIK3CG P48736 1/20 0.34
HDAC1 Q13547 1/20 0.34
WDR5 P61964 1/20 0.34
KMT2A Q03164 1/20 0.34
LCK P06239 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3760623 0.95 PSMB8 (0.41) PSMB8MAPKAPK2PIK3CDDRD2DRD4
SCHEMBL3760242 0.94 PSMB8 (0.38) PSMB8MAPKAPK2PIK3CDPIK3CBPIK3CA
SCHEMBL3766694 0.92 CXCR4 (0.38) PSMB8MAPKAPK2PIK3CDPIK3CBPIK3CA
SCHEMBL3754902 0.91 PSMB8 (0.35) PSMB8MAPKAPK2PIK3CDPIK3CBPIK3CA
SCHEMBL3760485 0.89 MAPKAPK2 (0.36) PSMB8MAPKAPK2PIK3CDPIK3CBPIK3CA
SCHEMBL3763305 0.89 CXCR4 (0.42) PSMB8MAPKAPK2BUB1TGFBR1JAK2
SCHEMBL16162228 0.89 PIK3CA (0.36) PSMB8MAPKAPK2PIK3CDPIK3CBPIK3R1
SCHEMBL3751951 0.89 PIK3CA (0.36) PSMB8MAPKAPK2PIK3CDPIK3CBPIK3R1
SCHEMBL3765017 0.89 BUB1 (0.36) PSMB8MAPKAPK2PIK3CDPIK3CBPIK3CA
SCHEMBL3763765 0.89 AOC3 (0.38) PIK3CDPIK3CBPIK3CABUB1PIK3CG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2029570-B1 FUSED THIOPHENE DERIVATIVES AS KINASE INHIBITORS UCB PHARMA SA (BE) 2014-10-15 EP disclosed
US-8324204-B2 Fused thiophene derivatives as kinase inhibitors UCB PHARMA SA (BE) 2012-12-04 US disclosed
US-20100305066-A1 Fused Thiophene Derivatives as Kinase Inhibitors UCB PHARMA S.A. (BE) 2010-12-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100305066-A1 Fused Thiophene Derivatives as Kinase Inhibitors PIKFYVE, PI4KA, PIK3CA PSMB8 2451/4885MAPKAPK2 53/4885PIK3CD 9/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.